
Ovid Therapeutics OVID
$ 2.73
1.48%
Annual report 2025
added 03-18-2026
Ovid Therapeutics PEG Ratio 2011-2026 | OVID
Annual PEG Ratio Ovid Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | 0.0814 | 0.0514 | 0.0288 | - | -0.211 | -0.0824 | -0.0408 | 0.0686 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.2 | -0.211 | 0.012 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.000157 | $ 9.13 | -0.76 % | $ 591 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.0951 | $ 0.91 | 2.42 % | $ 6.69 M | ||
|
Edesa Biotech
EDSA
|
-0.0119 | $ 15.52 | -2.39 % | $ 49.6 M | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.47 | 1.19 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Fortress Biotech
FBIO
|
0.044 | $ 2.24 | 0.9 % | $ 62.5 M | ||
|
Galectin Therapeutics
GALT
|
0.235 | $ 2.26 | 0.22 % | $ 144 M | ||
|
Galapagos NV
GLPG
|
0.0003 | $ 28.07 | 0.75 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.2 | 3.6 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 31.01 | -0.13 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
0.153 | $ 8.44 | - | $ 76.2 M | ||
|
InflaRx N.V.
IFRX
|
0.094 | $ 1.95 | -1.77 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
4.81 K | $ 0.83 | 3.44 % | $ 6.55 M | ||
|
Incyte Corporation
INCY
|
0.135 | $ 98.87 | -0.23 % | $ 19.3 B | ||
|
InMed Pharmaceuticals
INM
|
1.55 | $ 0.71 | 1.28 % | $ 1.74 M | ||
|
INmune Bio
INMB
|
-0.342 | $ 1.35 | 1.5 % | $ 33.4 M | ||
|
Innoviva
INVA
|
0.012 | $ 23.13 | 0.35 % | $ 1.56 B | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 104.54 | 2.92 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Jaguar Health
JAGX
|
-0.000005 | $ 7.55 | -4.13 % | $ 17.6 M | ||
|
KalVista Pharmaceuticals
KALV
|
0.311 | $ 26.67 | -0.02 % | $ 1.44 B | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.43 | -4.03 % | $ 235 M | ||
|
Kamada Ltd.
KMDA
|
1.39 | $ 8.15 | 0.49 % | $ 260 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Kazia Therapeutics Limited
KZIA
|
5.03 | $ 13.24 | 6.56 % | $ 1.75 B | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-5.01 | $ 223.98 | -0.39 % | $ 4.1 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.22 | 7.69 % | $ 5.3 M | ||
|
Liquidia Corporation
LQDA
|
0.000305 | $ 38.39 | 0.62 % | $ 3.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.08 | 0.74 % | $ 436 M |